Boston Scientific’s diverse medical portfolio acquired an incredible company and a revolutionary technology in Obsidio. We’re excited to see what Rosenman Founder and Obsidio CEO Ehsan Jabbarzadeh will do in this new era, and hope their technology will reach more and more doctors stopping hemorrhages and cancer complications across the country.
